Identification of unbalanced genomic aberrations by array cgh in chronic myeloid leukemia patients with suboptimal response to imatinib treatment
Saved in:
Main Authors: | Phan, C.L., Ang, C.H., Liang, K.L., Gan, G.G., Zakaria, Z., Nadarajan, V. |
---|---|
Format: | Article |
Published: |
Ferrata Storti Foundation
2010
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/13331/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of copy number alterations by array comparative genomic hybridization in patients with late chronic or accelerated phase chronic myeloid leukemia treated with imatinib mesylate
by: Nadarajan, V.S., et al.
Published: (2011) -
Imatinib mesylate in the treatment of chronic myeloid leukemia: a local experience
by: Bee, P.C., et al.
Published: (2006) -
The roles of ceramide generating and ceramide clearence genes in apoptosis in chronic myeloid leukemia cells exposed to dasatinib
by: Ang, C.H., et al.
Published: (2010) -
High resolution melt curve analysis as a tool for screening tyrosine kinase domain mutations in patients with chronic myeloid leukemia on tyrosine kinase inhibitors
by: Ang, C.H., et al.
Published: (2010) -
Detection of BCR-ABL T315i mutation in imatinib resistant chronic myeloid leukemia patients
by: Mardziah M,, et al.
Published: (2019)